| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.3 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |